Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Germ cell tumors of the central nervous system other than germinoma. This category includes teratoma, choriocarcinoma, embryonal carcinoma, and yolk sac tumor.
Biomarker and diagnostic research for central nervous system nongerminomatous germ cell tumor has been reported in the published literature.
1 clinical trial registered. Interventions under study include drug therapy, other interventions, procedural interventions, and biologic therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
21 publications have been identified in PubMed for central nervous system nongerminomatous germ cell tumor. Research spans Clinical Trial Publication (24%), Review / Meta-Analysis (19%), and Case Report / Case Series (19%).
Research Type | Count | % of Total |
|---|---|---|
Clinical study results | 5 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 8:44 AM UTC
24%
Research summaries | 4 | 19% |
Patient case studies | 4 | 19% |
Laboratory research | 3 | 14% |
Disease patterns and progression | 2 | 10% |
Other research | 1 | 5% |
Testing and diagnosis research | 1 | 5% |
New treatment approaches | 1 | 5% |
Tahuahua-Flores O (2026). [PMID: 41438535](https://pubmed.ncbi.nlm.nih.gov/41438535/). *Indian J Thorac Cardiovasc Surg*. [Case Report / Case Series]
Faure Conter C (2026). [PMID: 42115464](https://pubmed.ncbi.nlm.nih.gov/42115464/). *Adv Tech Stand Neurosurg*. [Review / Meta-Analysis]
Abu-Arja MH (2026). [PMID: 41996009](https://pubmed.ncbi.nlm.nih.gov/41996009/). *J Neurooncol*. [Clinical Trial Publication]
Takami H (2025). [PMID: 39492661](https://pubmed.ncbi.nlm.nih.gov/39492661/). *Neuro-oncology*. [Epidemiology / Natural History]
Capdevila P (2025). [PMID: 40304839](https://pubmed.ncbi.nlm.nih.gov/40304839/). *Clin Transl Oncol*. [Diagnostic / Biomarker]
Zhou Z (2025). [PMID: 39814246](https://pubmed.ncbi.nlm.nih.gov/39814246/). *Critical reviews in oncology/hematology*. [Review / Meta-Analysis]
Takami H (2025). [PMID: 41198340](https://pubmed.ncbi.nlm.nih.gov/41198340/). *Advances in cancer research*. [Gene Therapy / Novel Therapeutics]
Zhou J (2025). [PMID: 39958339](https://pubmed.ncbi.nlm.nih.gov/39958339/). *Frontiers in immunology*. [Basic Science / Preclinical]
Wang YF (2025). [PMID: 38821737](https://pubmed.ncbi.nlm.nih.gov/38821737/). *Journal of the Formosan Medical Association = Taiwan yi zhi*. [Epidemiology / Natural History]
Inoue S (2025). [PMID: 39359021](https://pubmed.ncbi.nlm.nih.gov/39359021/). *Neuropathology : official journal of the Japanese Society of Neuropathology*. [Review / Meta-Analysis]